The medication has been commonly prescribed to treat serious acne since the 1980s.

Objective To observe whether individualized treatment of severe acne patients can effectively decrease scars or avoid cicatrization.

These patients had acne vulgaris ranging from mild to severe and were a subgroup of patients from phase 3, randomized, double-blind, vehicle-controlled, multicenter clinical trials.